Role of MTA1 in head and neck cancers

Cancer and Metastasis Reviews

Volumn 33, Issue 4, 2014, Pages 953-964

  Marzook, Hezlin ^a   Deivendran, S ^a   Kumar, Rakesh ^a,b   Pillai, M Radhakrishna ^a  

^a RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Head and neck squamous cell carcinoma (HNSCC); Human papillomavirus (HPV); Invasion; Metastasis; Metastasis tumour antigen 1 (MTA1); Nasopharyngeal cancer (NPC)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CATHEPSIN D; ENDOSTATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; METASTASIS TUMOR ANTIGEN 1; METASTASIS TUMOR ANTIGEN 2; METASTASIS TUMOR ANTIGEN 3; PROTEIN E6; PROTEIN E7; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR ANTIGEN; UNCLASSIFIED DRUG; VASCULOTROPIN C; VIRUS DNA; HISTONE DEACETYLASE; MTA1 PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR MARKER;

ARTICLE; BONE METABOLISM; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL FEATURE; DISEASE COURSE; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CANCER; LARYNX CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS; NASOPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN UNFOLDING; TONGUE CANCER; TUMOR INVASION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEAD AND NECK TUMOR; PATHOLOGY;

GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HISTONE DEACETYLASES; HUMANS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; REPRESSOR PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84913530255     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-014-9521-5     Document Type: Article

References (70)

1. Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer, 127, 2893–2917.
2. Nair, S., & Pillai, M. R. (2005). Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Diseases, 11, 350–359.
3. Brumbaugh, J., Ferris, R. L., & Hu, S. (2011). HPV and EBV in head and neck cancer. In: Bernier J (Ed.) Head and neck cancer: Multimodality management. Springer Publisher, New York, 121–134.
4. Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., Kim, H., Axelrod, R., Silverman, C. C., Redmond, K. P., & Gillison, M. L. (2010). Human papillomavirus and survival of patients with oropharyngeal cancer. New England Journal of Medcine, 363, 24–35.
5. Bernier, J., & Cooper, J. S. (2005). Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? The Oncologist, 10, 215–224.
6. Boscolo-Rizzo, P., Maronato, F., Marchiori, C., Gava, A., & Da Mosto, M. C. (2008). Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope, 118, 300–306.
7. Kotwall, C., Sako, K., Razack, M. S., Rao, U., Bakamjian, V., & Shedd, D. P. (1987). Metastatic patterns in squamous cell cancer of the head and neck. The American Journal of Surgery, 154, 439–442.
8. Law, J. Y., Chen, S. A., Gerber, D. E., Hughes, R. S., Madrigales, A., Myers, L. L., Nedzi, L. A., Sumer, B. D., Truelson, J., Yordy, J. S., Zhu, H., & Khan, S. A. (2014). Patterns of distant metastases in HPV-positive head and neck squamous cell carcinoma. Journal of Clinical Oncology, 32.
9. O’Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., et al. (1997). Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277–285.
10. Homer, J. J., Greenman, J., & Stafford, N. D. (2002). Circulating angiogenic cytokines as tumor markers and prognostic factors in head and neck squamous cell carcinoma. Clinical Otolaryngology & Allied Sciences, 27, 7.
11. Berchem, G., Glondu, M., Gleizes, M., Brouillet, J. P., Vignon, F., Garcia, M., & Liaudet-Coopman, E. (2002). Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene, 21, 5951–5955.
12. Wolf, M., Clark-Lewis, I., Buri, C., Langen, H., Lis, M., & Mazzucchelli, L. (2003). Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. American Journal of Pathology, 162, 1183–1190.
13. Vigneswaran, N., Zhao, W., Dassanayake, A., Muller, S., Miller, D. M., & Zacharias, W. (2000). Variable expression of cathepsin B and D correlates with highly invasive and metastatic phenotype of oral cancer. Human Pathology, 31, 931–937.
14. Patel, B. P., Shah, S. V., Shukla, S. N., Shah, P. M., & Patel, P. S. (2007). Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head and Neck, 29, 564–572.
15. Sauter, E. R., Nesbit, M., Watson, J. C., Klein-Szanto, A., Litwin, S., & Herlyn, M. (1999). Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clinical Cancer Research, 5, 775–782.
16. Bock, J. M., Sinclair, L. L., Bedford, N. S., Jackson, R. E., Lee, J. H., & Trask, D. K. (2008). Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck. Archives of Otolaryngology - Head and Neck Surgery, 143, 355–362.
17. Hong, D.-Y., Lee, B.-J., Lee, J.-C., Choi, J.-S., & Wang, S.-G. (2009). Expression of VEGF, HGF, IL-6, IL-8, MMP-9, telomerase in peripheral blood of patients with head and neck squamous cell carcinoma. Clinical & Experimental Otorhinolaryngology, 2(4), 186–192.
18. Zohn, I. E., Li, Y., Skolnik, E. Y., Anderson, K. V., Han, J., & Niswander, L. (2006). p38 and p38 interacting protein are critical for downregulation of E-cadherin during mouse gastrulation. Cell, 125, 957–969.
19. Cohen, J., et al. (2009). Attenuated transforming growth factor β signaling promotes nuclear factor-κB activation in head and neck cancer. Cancer Research, 69, 3415–3424.
20. Leemans, C. R., Braakhauis, B. J., & Brakenhoff, R. H. (2011). The molecular biology of head and neck cancer. Nature Reviews Cancer, 11, 9–22.
21. Olivier, M., Hollstein, M., & Hainaut, P. (2010). TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harbor Perspectives in Biology, 2, a001008.
22. Werness, B. A., Levine, A. J., & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science, 248, 76–79.
23. Braakhuis, B. J., Leemans, C. R., & Brakenhoff, R. H. (2004). A genetic progression model of oral cancer: current evidence and clinical implications. Journal of Oral Pathology & Medicine, 33, 317–322.
24. Pillai, M. R., & Nair, M. K. (2000). Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors. Experimental and Molecular Pathology, 69, 233–241.
25. Schache, A. G., Liloglou, T., Risk, J. M., Filia, A., Jones, T. M., Sheard, J., Woolgar, J. A., Helliwell, T. R., Triantafyllou, A., Robinson, M., Sloan, P., Harvey-Woodworth, C., Sisson, D., & Shaw, R. J. (2011). Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clinical Cancer Research, 17, 6262–6271.
26. Iancu, B. A., IV, Goia-Ruşanu, C. D., Stănescu, A., Huică, I., Nistor, E., Anton, G., & Pleşa, A. (2010). TGF-beta signalling pathway factors in HPV-induced cervical lesions. Roumanian Archives of Microbiology and Immunology, 69, 113–118.
27. Lu, S. L., et al. (2006). Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes & Development, 20, 1331–1342.
28. Trobridge, P., Knoblaugh, S., Washington, M. K., Munoz, N. M., Tsuchiya, K. D., & Rojas, A. (2009). TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. Gastroenterology, 136, 1680–1688.
29. Prokopakis, P., Sourvinos, G., Koumantaki, Y., Koumantakis, E., & Spandidos, D. A. (2002). K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix. Oncology Reports, 9, 129–133.
30. Acuña Sanhueza, G. A., Faller, L., George, B., Koffler, J., Misetic, V., Flechtenmacher, C., Dyckhoff, G., Plinkert, P. P., Angel, P., Simon, C., & Hess, J. (2012). Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells. BMC Cancer, 12.
31. Roepman, P., et al. (2005). An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nature Genetics, 37, 182–186.
32. Zhang, R., & Song, C. (2014). Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. Tumour Biology, 35(5), 4419–4423.
33. Bernier, J. (2008). Drug insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck. Nature Clinical Practice Oncology, 5, 705–713.
34. Wieduwilt, M. J., & Moasser, M. M. (2008). The epidermal growth factor receptor family: biology driving targeted therapeutics. Cellular and Molecular Life Sciences, 65, 1566–1584.
35. Richard, V., & Pillai, M. R. (2010). The stem cell code in oral epithelial tumorigenesis: ‘the cancer stem cell shift hypothesis’. Biochimica et Biophysica Acta (BBA), 1806, 146–162.
36. Kumar, R., Wang, R. A., & Bagheri-Yarmand, R. (2003). Emerging roles of MTA family members in human cancers. Seminars in Oncology, 30, 30–37.
37. Li, D. Q., Pakala, S. B., Nair, S. S., Eswaran, J., & Kumar, R. (2012). Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Research, 72, 387–394.
38. Li, S. H., Tian, H., Yue, W. M., Li, L., Gao, C., Li, W. J., Hu, W. S., & Hao, B. (2012). Metastasis-associated protein 1 nuclear expression is closely associated with tumor progression and angiogenesis in patients with esophageal squamous cell cancer. World Journal of Surgery, 36, 623–631.
39. Schultz, J. D., Sommer, J. U., Hoedt, S., Erben, P., Hofheinz, R. D., Faber, A., Thorn, C., Hörmann, K., & Sauter, A. (2011). Chemotherapeutic alteration of β-catenin and c-kit expression by imatinib in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro. Oncology Reports, 27, 270–280.
40. Stewart, S., Dawson, C. W., Takada, K., Curnow, J., Moody, C. A., Sixbey, J. W., & Young, L. S. (2004). Epstein–Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-κB transcription factor pathway. Proceedings of the National Academy of Sciences, 101, 15730–15735.
41. Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., Wang, S., Ren, P., Martin, M., Jessen, K., Feldman, M. E., Weissman, J. S., Shokat, K. M., Rommel, C., & Ruggero, D. (2012). The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature, 485, 55–61.
42. Lin, Z., Wan, X., Jiang, R., Deng, L., et al. (2014). EBV-encoded LMP2A promotes EMT in nasopharyngeal carcinoma via MTA1 and mTOR signaling induction. Journal of Virology, 88(20):11872–85.
43. Cho, C. Y., Wang, J. H., Chang, H. C., et al. (2007). Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. Journal of Cellular Physiology, 213, 65–69.
44. Prasad, N. B., Fischer, A. C., Chuang, A. Y., Wright, J. M., Yang, T., Tsai, H. L., Westra, W. H., Liegeois, N. J., Hess, A. D., & Tufaro, A. P. (2014). Differential expression of degradome components in cutaneous squamous cell carcinomas. Modern Pathology, 27, 945–957.
45. Sasahara, R. M., Brochado, S. M., Takahashi, C., Oh, J., Maria-Engler, S. S., Granjeiro, J. M., Noda, M., & Sogayar, M. C. (2002). Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detection and Prevention, 26, 435–443.
46. Deng, Y., Zhou, D., & Zeng, L. (2011). Expression and significance of MTA1 and RECK gene in nasopharyngeal carcinoma. Lin Chung Er Bi Yan HouTou Jing WaiKeZaZhi, 25, 534–538.
47. Song, Q., Zhang, H., Wang, M., & Song, W. (2013). MTA1 promotes nasopharyngeal carcinoma growth in vitro and in vivo. Journal of Experimental & Clinical Cancer Research, 31, 54.
48. Rathinam, R., Berrier, A., & Alahari, S. K. (2011). Role of Rho GTPases and their regulators in cancer progression. Frontiers in Bioscience, 17, 2561–2571.
49. Bailey, J. M., Mohr, A. M., & Hollingsworth, M. A. (2009). Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene, 28, 3513–3525.
50. Song, Q., Li, Y., Zheng, X., Fang, Y., Chao, Y., Yao, K., & Zhu, X. (2013). MTA1 contributes to actin cytoskeleton reorganization and metastasis of nasopharyngeal carcinoma by modulating Rho GTPases and Hedgehog signaling. The International Journal of Biochemistry & Cell Biology, 45, 1439–1446.
51. Roepman, P., de Jager, A., Marian, J. A., Koerkamp, G., et al. (2006). Maintenance of head and neck tumor gene expression profiles upon lymph node metastasis. Cancer Research, 66, 11110.
52. Kawasaki, G., Yanamoto, S., Yoshitomi, I., Yamada, S., & Mizuno, A. (2008). Overexpression of metastasis-associated MTA1 in oral squamous cell carcinomas: correlation with metastasis and invasion. International Journal of Oral and Maxillofacial Surgery, 37, 1039–1046.
53. Wang, H., Huang, G., Wei, F., Mo, L., & Kuang, G. (2006). Correlation between expression of the MTA1 gene and carcinomas of larynx. Lin Chuang Er Bi Yan HouKeZaZhi. (Chinese), 20, 113–115.
54. Tang, Q. F., Ji, W. Y., Pan, Z. M., Zheng, Y., & Guan, C. (2003). Expression of the metastasis-associated gene 1 in laryngeal squamous cell carcinoma: correlation with cervical lymph node metastasis. ZhonghuaEr Bi Yan HouKeZaZhi. (Chinese), 38, 213–216.
55. Forastiere, A., Koch, W., Trotti, A., & Sidransky, D. (2001). Head and neck cancer. New England Journal of Medicine, 345,1890–1900.
56. Park, J. O., Jung, C. K., Sun, D. I., Joo, Y. H., & Kim, M. S. (2011). Relationships between metastasis-associated protein (MTA) 1 and lymphatic metastasis in tonsil cancer. European Archives of Otorhinolaryngology, 268, 1329–1334.
57. Liu, T., Yang, M., Yang, S., Ge, T., Gu, L., & Lou, G. (2013). Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer. Human Pathology, 44, 2275–2281.
58. Li, W.-F., Liu, N., Cui, R.-X., He, Q.-M., Chen, M., Jiang, N., Sun, Y., Zeng, J., Liu, L.-Z., & Ma, J. (2012). Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma. Journal of Translational Medicine, 10, 78.
59. Liu, J., Xu, D., Wang, H., Zhang, Y., & Chang, Y. (2014). The subcellular distribution and function of MTA1 in cancer differentiation. Oncotarget, 5, 5153–5164.
60. Yu, C. H., Chen, H. H., Wang, J. T., et al. (2007). Nuclear expression of metastasis-associated protein 1 (MTA1) is inversely related to progression of oral squamous cell carcinoma in Taiwan. Journal of Dental Sciences, 2.
61. Luo, J., Su, F., Chen, D., et al. (2000). Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature, 408, 377–381.
62. Yang, W., Cai, Q., Lui, V.W., Everley, P.A., Kim, J., Bhola, N., Quesnelle, K.M., Zetter, B.R., Steen, H., Freeman, M.R., & Grandis, J.R. (2010). Quantitative proteomics analysis reveals molecular networks regulated by epidermal growth factor receptor level in head and neck cancer. J Proteome Res, 9, 3073-3082
63. Ambatipudi, S., Gerstung, M., Pandey, M., Samant, T., et al. (2012). Genome-wide expression and copy number analysis identifies driver genes in gingivobuccal cancers. Genes, Chromosomes & Cancer, 51, 161–173.
64. Peng, C.-H., Liao, C. T., Peng, S.-C., Chen, Y.-J., Cheng, A.-J., Juang, J.-L., Tsai, C.-Y., Chen, T.-C., Chuang, Y.-J., Tang, C.-Y., Hsieh, W.-P., & Yen, T.-C. (2011). A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One, 6.
65. Estilo, C. L., O-charoenrat, P., Talbot, S., Socci, N. D., et al. (2009). Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer, 9.
66. Frierson, H. F., Jr., El-Naggar, A. K., Welsh, J. B., Sapinoso, L. M., Su, A. I., Cheng, J., Saku, T., Moskaluk, C. A., & Hampton, G. M. (2002). Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma. American Journal of Pathology, 161, 1315–1323.
67. Bagheri-Yarmand, R., Talukder, A. H., Wang, R. A., Vadlamudi, R. K., & Kumar, R. (2004). Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development, 131, 3469–3479.
68. Pakala, S. B., Singh, K., Reddy, S. D., Ohshiro, K., Li, D. Q., Mishra, L., et al. (2011). TGF-b1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene, 30, 2230–2241.
69. Dannenmann, C., Shabani, N., Friese, K., Jeschke, U., Mylonas, I., & Brüning, A. (2008). The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biology and Therapy, 7, 1460–1467.
70. Kumar, R., Balasenthil, S., Manavathi, B., Rayala, S. K., & Pakala, S. B. (2010). Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor. Cancer Research, 70, 6649–6658.